Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01243151 · ClinicalTrials.gov registry record · Phase 1
Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia
A Phase 1 study of Hypercholesterolemia and Dyslipidemia, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 68
- Enrollment target
- 9
- Study locations
NCT01243151 is a Phase 1 study of Hypercholesterolemia and Dyslipidemia that has completed, run by Pfizer. The registered enrollment target is 68 participants, below the 816-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (92% lower). The trial reports 9 study locations across 6 states.
The verdict
NCT01243151, a Phase 1 study of Hypercholesterolemia and Dyslipidemia, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 68 participants
- Enrollment target
- 9
- Study locations
Study Summary
The primary objective of this study is to evaluate the safety and tolerability of repeated doses of PF-04950615 (RN316) in study volunteers with hypercholesterolemia. PF-04950615 is an investigational drug that is currently being studied as a lipid lowering agent.
Conditions Studied
Interventions
- BIOLOGICAL PF-04950615 (RN316)
Study Locations (9)
California
- California Clinical Trials Medical Group - Culver City
- Glendale Adventist Medical Center - Glendale
Florida
- SeaView Research, Inc. - Miami
- SeaView Research, Inc. - Miami
Kansas
- Vince and Associates Clinical Research - Overland Park
- Vince and Associates Clinical Research - Overland Park
Hawaii
- Covance Clinical Research Unit, Inc. - Honolulu
Minnesota
- Prism Research - Saint Paul
Texas
- Healthcare Discoveries, LLC dba ICON Development Solutions - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01243151
The ClinicalTrials.gov registry entry for NCT01243151 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (92% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypercholesterolemia appearing as the primary indexed condition, and to 1 intervention - of which PF-04950615 (RN316) is the first listed.
NCT01243151 reports 9 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Kansas.
Frequently Asked Questions
What is clinical trial NCT01243151 about?
NCT01243151 is a clinical study titled "Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia". The primary objective of this study is to evaluate the safety and tolerability of repeated doses of PF-04950615 (RN316) in study volunteers with hypercholesterolemia. PF-04950615 is an investigational drug that is currently being studied as a lipid lowering agent.
What is the current status of trial NCT01243151?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 68 participants. The study started on 2011-02. Estimated completion is 2011-10.
What conditions does trial NCT01243151 study?
This clinical trial studies the following conditions: Hypercholesterolemia, Dyslipidemia.
What interventions are being tested in trial NCT01243151?
The interventions under investigation include: PF-04950615 (RN316) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01243151?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01243151 being conducted?
This trial has 9 study locations across California, Florida, Hawaii, Kansas, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypercholesterolemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of the Response of Human Small Blood Vessels
COMPLETED · Phase 1
-
A Study of LY3015014 in Healthy Participants With High Cholesterol
COMPLETED · Phase 1
-
Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia
COMPLETED · Phase 1
-
Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults
COMPLETED · Phase 1
-
Potential Risk Factors for Stroke
COMPLETED · Phase 1
-
Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.